Attention Deficit Hyperactivity Disorder (ADHD) Clinical Trial
Official title:
The Correlation Between Blood omega3 and ADHD
Attention deficit hyperactivity disorder (ADHD) is a major problem in children and
adolescents. Clinical and biochemical evidence suggests that deficiencies of polyunsaturated
fatty acids (PUFA) could be related to ADHD. PUFAs are the major components of brain with
important physiologically active functions.
Aim: Study the relationship between omega3 blood values and ADHD clinical status.
Methods: The investigators will recruit 30 children, who have been diagnosed with ADHD by a
child psychiatrist. In addition the investigators will recruit a control group of 30
children without ADHD and related neuropsychiatric syndromes. Blood will be taken from all
children.
The ADHD children will be asked to consume omega3 capsules for 6 month. After 3 and 6
months, all children will undergo clinical examination and blood tests will be taken for
omega3 index analysis. Blind frozen samples of isolated red blood cell (RBC) will be
analyzed according to the omega3 index methodology.
Attention deficit hyperactivity disorder (ADHD) is a major problem in children and
adolescents. Clinical and biochemical evidence suggests that deficiencies of polyunsaturated
fatty acids (PUFA) could be related to ADHD. PUFAs are the major components of brain with
important physiologically active functions.
Aim: To investigate influence effects of omega3 dietary supplementation on ADHD symptoms and
the measured blood values.
Methods: The study will be authorized by the Ziv Helsinki Committee and the Ministry of
Health. Written Informed consent will obtained from parents. The investigators will recruit
30 children, who have been diagnosed with ADHD by a child psychiatrist. In addition the
investigators will recruit a control group of 30 children without ADHD and related
neuropsychiatric syndromes. Blood will be taken from all children.
;
Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Supportive Care
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03260205 -
Safety and Efficacy Study in Preschool Children Aged 4-5 Years With Attention-deficit/Hyperactivity Disorder (ADHD)
|
Phase 3 | |
Withdrawn |
NCT03546400 -
Safety, Tolerability and PK Study of Methylphenidate HCl ERCT in 4-5 Year Old Children With ADHD.
|
Phase 4 | |
Completed |
NCT02917109 -
LearningRx Cognitive Training for ADHD
|
N/A | |
Completed |
NCT02248948 -
Superiority of Omega-3 Versus Placebo on the Improvement of ADHD in Children
|
N/A | |
Recruiting |
NCT01750307 -
The Relationship of Essential Fatty Acids to Adult ADHD: The OCEAN Study (Oils and Cognitive Effects in Adult ADHD Neurodevelopment)
|
N/A | |
Recruiting |
NCT06170996 -
Internet-Assisted Behavioral Parent Training Intervention for Children With Attention Deficit Hyperactivity Disorder
|
N/A | |
Completed |
NCT00735371 -
Efficacy and Safety of Lisdexamfetamine Dimesylate (LDX) in Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD)
|
Phase 3 | |
Withdrawn |
NCT03580005 -
A 6-week Study to Evaluate the Safety and Efficacy of Quillichew ERCT in 4-5 Year Old Children With ADHD.
|
Phase 4 | |
Completed |
NCT02578030 -
Pharmacokinetic Study in Children and Adolescents Aged 6 to 17 Years Who Have Been Diagnosed With ADHD
|
Phase 1 | |
Completed |
NCT02574273 -
Pilot Trial of a Social Skills Group Treatment (Secret Agent Society Program)
|
N/A | |
Completed |
NCT02257216 -
Vayarin® Medical Food Study for Adults With Attention Deficit Hyperactivity Disorder (ADHD)
|
N/A | |
Recruiting |
NCT04943796 -
A Study to Learn About the Occurrence of ADHD in Adults With Mental Conditions and Their Quality of Life
|
||
Recruiting |
NCT04634006 -
Home-Based tDCS in Children With ADHD: A Randomized, Sham-Controlled tDCS and fNIRS Study
|
N/A | |
Active, not recruiting |
NCT02908802 -
Probiotic Supplement as Treatment for Students With ADHD
|
N/A | |
Completed |
NCT02604407 -
Safety and Efficacy Study of SHP465 in Adults Aged 18-55 Years With Attention-deficit/ Hyperactivity Disorder (ADHD)
|
Phase 3 | |
Completed |
NCT05870605 -
Drug Use Study With Intuniv® in European Countries
|
||
Terminated |
NCT03481959 -
Effectiveness of Methylphenidate Late Formula to Reduce Cannabis Use in Young Cannabis-Related Patients and Attention Deficit Disorder Hyperactivity
|
Phase 3 | |
Terminated |
NCT03638466 -
Exploratory fMRI Study on the Treatment for Impulsive Aggression in Children With Attention-Deficit/Hyperactivity Disorder
|
Phase 2 | |
Completed |
NCT03709940 -
Brain Connectivity in Attention Deficit Hyperactivity Disorder (ADHD)
|
N/A | |
Completed |
NCT02795637 -
Study of the What the Body Does to the Drug in Subjects With Mild, Moderate, and Severe Liver Dysfunction
|
Phase 1 |